Continuous infusion of doxorubicin has been a strategy to reduce cardiotoxicity. Epirubicin is another anthracycline in common clinical use. However, evidence is lacking regarding whether this strategy can reduce cardiotoxicity of epirubicin without compromising antineoplastic efficacy.
Pubmed ID: 29131861 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Cell line 4T1-Luc [JCRB] is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionslaboratory mouse with name BALB/cAnNCrl from MGI.
View all literature mentions